Europe’s biotech firms flocking to Bay State

Companies cite potential for growth, talent in area

Massachusetts, often considered a difficult place to do business, is becoming a popular choice for a key global sector: European life sciences companies.

Executives from the Continent’s pricey precincts are unfazed by Boston-area costs and the trans-Atlantic flights. And they see the Massachusetts biomedical cluster as a gateway to a US market that increasingly looks like a safe haven from Europe’s debt crisis.

Your comment is subject to the rules of our Posting Policy

This comment may appear on your public profile. Public Profile FAQ

We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of